Evidence map›Paper›PMID 30671539›Full record

ArticleCannabis and cannabinoid research2018

Synthetic Cannabinoid Activity Against Colorectal Cancer Cells.

Wesley M Raup-Konsavage, Megan Johnson, Christopher A Legare, Gregory S Yochum, Daniel J Morgan, Kent E Vrana

Open access · hybridAbstract read
In one paragraph

Article in Cannabis and cannabinoid research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review: Cannabinoids as Medicinals.Current addiction reports · 2022
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wesley M Raup-KonsavageDepartment of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
Megan JohnsonDepartment of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
Christopher A LegareDepartment of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
Gregory S YochumDepartment of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
Daniel J MorganDepartment of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
Kent E VranaDepartment of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
Pennsylvania State University · US

Funding

Mechanisms of cannabinoid toleranceR01DA044999 · NIDA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI GUINDON, JOSEE, MORGAN, DANIEL J · 2018 to 2022
$2.4M
Desensitization and downregulation of CB1 during cannabinoid toleranceK01DA037355 · NIDA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MORGAN, DANIEL J · 2015 to 2017
$476k
NIDA NIH HHS K01 DA037355NIDA NIH HHS R01 DA044999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CBDcolorectal cancersynthetic cannabinoidsTHC

Identifiers

PMID30671539
PMCPMC6340378
OpenAlexW2905736342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.